Menu

Articles by : Luke Zarzecki, National Correspondent

Economists Push for Classifying 340B as a Tax Expenditure; 340B Providers Push Back

Luke Zarzecki, National Correspondent 340B Report Views
A recent Health Affairs Forefront piece argued that classifying 340B as a tax expenditure would provide more context for discussions on reforming the federal drug pricing program.
Two economists with previous ties to a pharmaceutical industry-funded patient advocacy group recently argued that classifying 340B as a tax [...]

Please Login or Become a Paid Subscriber to View this Content

…
Read More »

State Contract Pharmacy Lawsuit Roundup: Actions in Maryland, Colorado, North Dakota and Utah

Luke Zarzecki, National Correspondent 340B Report Views
Key actions occurred in litigation over state 340B contract pharmacy laws in Maryland, Colorado, North Dakota and Utah.
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...]

Please Login or Become a Paid Subscriber to View this Content

…
Read More »

Exclusive

Bergman, Ruiz to Introduce Bipartisan Bill Exempting Additional Covered Entities From 340B Rebates

Luke Zarzecki, National Correspondent 340B Report Views
U.S. Reps. Jack Bergman (R-Mich.) and Raul Ruiz (D-Calif.) are expected to soon introduce legislation to exempt certain covered entities from a 340B rebate model.
An expected bipartisan-backed U.S. House bill would exempt a range of covered entities, but not major hospitals, from 340B rebates—building [...]

Please Login or Become a Paid Subscriber to View this Content

…
Read More »

Virginia Drug Affordability Panel Bill Heads Back to Spanberger After Legislature Rejects Amendments

Luke Zarzecki, National Correspondent 340B Report Views
Virginia Gov. Abigail Spanberger (D) will soon decide the fate of a bill that would establish provisions similar to a prescription drug affordability board.
The fate of a Virginia prescription drug affordability advisory panel is in jeopardy after the state legislature rejected Gov. Abigail [...]

Please Login or Become a Paid Subscriber to View this Content

…
Read More »

AHA, 340B Health Defend 340B Program After Washington Post Editorial 

Luke Zarzecki, National Correspondent 340B Report Views
The American Hospital Association and 340B Health responded to a recent editorial in the Washington Post that criticized the 340B program.
Two leading 340B provider lobbyists recently came to the program’s defense in a pair of letters to the editor after [...]

Please Login or Become a Paid Subscriber to View this Content

…
Read More »

Senate HELP Committee Witness Elaborates on Call to Replace Current 340B Discount with Subsidy Program 

Luke Zarzecki, National Correspondent 340B Report Views
Ryan Long is a witness at Senate HELP Committee hearing
Ryan Long, director of congressional relations and senior research fellow at the Paragon Health Institute, expanded on a proposal to replace the 340B program with a direct subsidy program.
A witness who last week called for wholesale change in how the 340B program is structured at a U.S. Senate [...]

Please Login or Become a Paid Subscriber to View this Content

…
Read More »

Upcoming Senate HELP Hearing on Drug Pricing to Include Two Witnesses Critical of 340B Program

Luke Zarzecki, National Correspondent 340B Report Views
Sen. Bill Cassidy holds a gavel
U.S. Sen. Bill Cassidy (R-La.) will convene the Senate Health, Education, Labor and Pensions Committee for a hearing on April 16 entitled "Making Medicines More Affordable: How Competition Can Lower Drug Prices.”
A key Senate committee will hold a hearing this week on how to lower drug prices, featuring two witnesses who’ve [...]

Please Login or Become a Paid Subscriber to View this Content

…
Read More »

State Contract Pharmacy Lawsuit Roundup: Actions in Tennessee, Washington, Rhode Island and Maine

Luke Zarzecki, National Correspondent 340B Report Views
Courtroom
Key actions occurred in litigation over state 340B contract pharmacy laws in Tennessee, Washington, Rhode Island and Maine.
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...]

Please Login or Become a Paid Subscriber to View this Content

…
Read More »

White House Announces Tariffs on Drugmakers That Do Not Negotiate MFN Prices, U.S. Manufacturing Commitments

Luke Zarzecki, National Correspondent 340B Report Views
A screenshot of the presidential proclamation announcing the tariffs
The Trump administration announced on April 2 that pharmaceutical manufacturers will face new tariffs unless they negotiate a "most favored nation" price and begin to onshore their production of drugs.
The White House unveiled plans last week to set 100% tariffs on brand-name imported drugs with a number of exceptions, [...]

Please Login or Become a Paid Subscriber to View this Content

…
Read More »

Tennessee Attorney General’s Office Warns Novo Nordisk that In-House 340B Claims Data Requirements Violate State Law

Luke Zarzecki, National Correspondent 340B Report Views
Novo Nordisk exterior building signage
The Tennessee Attorney General's Office warned Novo Nordisk in a March 30 letter that its new in-house claims data requirements violated state law.
The Tennessee Attorney General’s office this week urged a Danish drugmaker against implementing new in-house claims data requirements that the [...]

Please Login or Become a Paid Subscriber to View this Content

…
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Site Footer Live

; ?>